DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Durezol (Difluprednate) - Off Label Use - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Off Label Use (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Durezol (Difluprednate) where reactions include off label use. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Durezol side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-25

Patient: male, weighing 95.3 kg (209.6 pounds)

Reactions: Off Label Use, Wrong Technique in Drug Usage Process, Bacterial Infection, Toxic Anterior Segment Syndrome

Drug(s) suspected as cause:
Nevanac
    Dosage: (ophthalmic)
    Indication: Cataract Operation

BSS
    Dosage: (intraocular), (intraocular)
    Indication: Cataract Operation
    Start date: 2011-11-15
    End date: 2011-11-15

BSS
    Dosage: (intraocular), (intraocular)
    Indication: Cataract Operation
    Start date: 2011-11-15
    End date: 2011-11-15

Vigamox
    Dosage: (ophthalmic)
    Indication: Cataract Operation

Tetracaine Polygyl Sterile Ophthalmic Solution
    Dosage: (ophthalmic)
    Indication: Cataract Operation
    Start date: 2011-11-15
    End date: 2011-11-15

BSS

Durezol
    Dosage: (ophthalmic)
    Indication: Cataract Operation

Other drugs received by patient: Dexamethasone TAB; Povidone Iodine



Possible Durezol side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-25

Patient: male, weighing 83.9 kg (184.6 pounds)

Reactions: Off Label Use, Toxic Anterior Segment Syndrome

Drug(s) suspected as cause:
BSS

Nevanac
    Dosage: (ophthalmic)
    Indication: Cataract Operation

Durezol
    Dosage: (ophthalmic)
    Indication: Cataract Operation

Tetracaine Polygyl Sterile Ophthalmic Solution
    Dosage: (ophthalmic)
    Indication: Cataract Operation
    Start date: 2011-11-15
    End date: 2011-11-15

Vigamox
    Dosage: (ophthalmic)
    Indication: Cataract Operation

BSS
    Dosage: (intraocular) ; (intraocular)
    Indication: Cataract Operation
    Start date: 2011-11-15
    End date: 2011-11-15

BSS
    Dosage: (intraocular) ; (intraocular)
    Indication: Cataract Operation
    Start date: 2011-11-15
    End date: 2011-11-15

Other drugs received by patient: Povidone Iodine; Dexamethasone

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017